开始
jhains2

AKAO Rounding Bottom in Place Ahead of 6/25 FDA Meeting Date

做多
jhains2  
NASDAQ:AKAO   None
Chart Patterns Beyond Technical Analysis
1
0
chartpattern beyondta
The FDA will consider AKAO's lead drug on June 25th.

The stock appears to have put in a solid bottom ahead of that meeting.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。